Form D · Venture Capital Fund

venBio Global Strategic Fund III, L.P.

San Francisco, CA · CIK 0001739920

Offering snapshot reported Mar 26, 2020 · SEC filing

Reported sold
$386M
Offering amount: $386M
Investors reported
100
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 14, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$193M$386MJun 13, 2018Mar 26, 2019: $118,000,000.00Mar 26, 2019Mar 26, 2020: $386,055,000.00Mar 26, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$118,000,000 → $386,055,000
  • Reported investors8 → 100
  • Minimum accepted$5,000,000 → $0

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 26, 2020Amendment$386,055,000$268,055,000vs Mar 26, 2019100SEC filing
Mar 26, 2019Amendment$118,000,000No comparison8SEC filing
Jun 13, 2018InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-314554
The amount of sales commissions and finders' fees paid in connection with the offering will be determined at the final closing of the issuer.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Far Hills Group LLC32243
BA Securities, LLC153489

Source: Form D, filed Mar 26, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

VENBIO GLOBAL STRATEGIC FUND III, LP

Investment adviser: VENBIO PARTNERS LLC

Gross asset value
$393M
Beneficial owners
103
ADV minimum commitment
$0

Reported in Form ADV on Mar 12, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT SAN FRANCISCO, California, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG, LLP SAN FRANCISCO, California, United States
Custodian MORGAN STANLEY & CO. LLC SAN FRANCISCO, California, United States Related to adviser: No
Custodian SILICON VALLEY BANK SAN FRANCISCO, California, United States Related to adviser: No
Marketer BA SECURITIES, LLC SAN DIEGO, California, United States Related to adviser: No
Marketer FAR HILLS GROUP, LLC. NEW YORK, New York, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
Yes

KPMG, LLP
PCAOB 185

MORGAN STANLEY & CO. LLC
SEC 8-15869

SILICON VALLEY BANK
LEI 0K2D5AK28E3O5CC06E35

BA SECURITIES, LLC
CRD 153489 · SEC 8-68545

FAR HILLS GROUP, LLC.
CRD 32243 · SEC 8-45675

Filing source

Form ADV 2064569 · Mar 12, 2026 · Schedule D 7.B.(1), fund 805-2838392619

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Adelman Director
Corey Goodman Director
David Pezeshki Executive
Aaron Royston Executive
N/A Ven Bio Global Strategic Gp Iii, L.P. Director
N/A Ven Bio Global Strategic Gp Iii, Ltd. Director

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
1700 Owens Street Suite 595
San Francisco, CA, 94158